Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Shareholder vote results
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. ARS Other Annual Report to Security Holders
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Planned sale Chief Legal Officer sold 5,674 shares at $18.35 ($104,122)
  18. 4 Planned sale CEO sold 30,663 shares at $18.35 ($562,684)
  19. 4 Planned sale President sold 7,434 shares at $18.35 ($136,418)
  20. 4 Planned sale SVP, Finance and Treasurer sold 3,015 shares at $18.35 ($55,330)

Page 6 of 26 · 514 filings